Trending...
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Kuester Management Group Breaks Down HOA Management Agreement Guidelines
- Powerful Leadership Transition to Optimize Highly Promising AI Platform RenovaroCube for Multi-Cancer Early Detection & Monitoring: Stock Symbol: RENB
SAN JOSE, Calif. - ncarol.com -- CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods. As a globally recognized peptide and oligonucleotide manufacturer, with our facilities built and operated to WHO GMP, FDA 21 CFR 210/211, and ICH Q7 standards, this audit marks a significant milestone in the company's ongoing commitment to ensuring the highest standards of quality and compliance. Our manufacturing facility in Hangzhou, China, was awarded an A2 compliance rating. This inspection certifies Good Manufacturing Practice (GMP) compliance of three commercial peptide active pharmaceutical ingredients (APIs). This achievement underscores our commitment to maintaining the highest quality standards in peptide production and ensures that our products meet stringent international regulatory requirements.
More on ncarol.com
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on ncarol.com
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
More on ncarol.com
- Balam and Transfera Unveil the World's First Remittance-as-a-Service Platform
- Minor Use Foundation Awarded $2M Grant from Assisting Specialty Crop Exports Initiative
- AI-driven money-saving tips: Black Friday shopping guide for 2024
- myStaze: Revolutionizing Live Music Streaming in the U.S. – Artists Earn 90% of Ticket Sales!
- ICONS OF ORIGINALITY: VALVOLINE™ GLOBAL OPERATIONS UNITES ASTON MARTIN ARAMCO'S JESSICA HAWKINS AND NASCAR HALL OF FAMER JEFF GORDON FOR HISTORIC DRIVER MATCHUP IN CHARLOTTE
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on ncarol.com
- Crosby Tatum's "The People, United" heads to Georgia & New York City during 2024 US General Election Season
- Terror Strikes - not if, but when, and Fight? Flight? Third option
- X3 Build Shares 4 Essential Questions to Ask a Custom Home Builder in Santa Monica Before Hiring Them
- Hel Todd Jr. Celebrate His Birthday! – A Special Opportunity to Bless a Young Boy in Need
- LIBRE's Cesar Grajales Tops the #1 Rankings for Spanish Radio Stations in Miami
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
Source: CPC Scientific Inc.
0 Comments
Latest on ncarol.com
- Arthur Murray Dance Studio of Denville: Dance Your Way to Joy and Confidence in North Jersey
- Arthur Murray Dance Studio of Napa: Discover the Joy of Dance in Wine Country
- Not Sure If Your Work Makes a Difference? Hear What God Is Saying to You Today
- Hillsborough Gallery of Arts Previews Orange County Artists Guild Studio Tour
- Better Termite & Pest Control Marks 56 Years of Fall Pest Protection
- Halloween Spending Surge Drives U.S. Holiday Economy Growth in 2024
- People are Having Millions of Conversations with Friends and Family About Voting in the 2024 Election
- 5 Questions to Always Ask Roofing Companies in Memphis Before Hiring Them
- David Boland, Inc. Awarded $42.6M Construction Contract With U.S. Army Corps of Engineers, Wilmington
- Lifesaving Portable, AI Augmented Cardiac Monitoring Technology Poised for Commercial Launch Under New Industry Leader: Heartbeam: Stock Symbol: BEAT
- KeysCaribbean Extends Advance Purchase Rate Discount Offer
- Kenneth Carnesi, Sr. COO Anaptyx Honored with 2024 Global Recognition Award
- Mount Dora Craft Fair and Plant Festival set to go on after hurricane hit
- ConverzAI Accelerates Industry Transformation with Groundbreaking AI-Powered Virtual Recruiters
- Cummings Graduate Institute for Behavioral Health Studies Celebrates 10 Years of Excellence in Integrated Behavioral Healthcare Education
- Significant Leaps Redefining Digital Commerce Connecting Merchants & Shoppers Rewarding Customers with Instant Cash Rebates (Stock Symbol: STBX)
- Michele Vreeland Explores the Supernatural with Haunting New Single 'Soul Collector,' Releasing October 25th, Just in Time for Halloween
- Nadia C. Vanderhall Named to Johnson C. Smith University's Forty Under 40, Class of 2024
- Jude Madrigal releases his first children's book, "The Trick-or-Treat Tree and the First Halloween."
- Powerful Leadership Transition to Optimize Highly Promising AI Platform RenovaroCube for Multi-Cancer Early Detection & Monitoring: Stock Symbol: RENB